Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease liver disease
Symptom C0020541|portal hypertension
Sentences 54
PubMedID- 24820314 Hps is a significant complication of portal hypertension in children with chronic liver disease and is an established indication for lt.
PubMedID- 24759352 The patient was diagnosed as having chronic liver disease with portal hypertension, with etiology probably related to non-alcoholic steatohepatitis (nash), with present decompensation due to drug-induced liver injury and sbp due to s. typhimurium.
PubMedID- 25899245 A diagnosis was made if they had features of chronic liver disease with evidence of portal hypertension, ascites, encephalopathy or liver and spleen imaging consistent with cirrhosis.
PubMedID- 21712949 Further evaluation showed that he had chronic liver disease with portal hypertension and was hepatitis b surface antigen-positive, indicating hepatitis b infection.
PubMedID- 24142390 The insertion of a transjugular intrahepatic portosystemic shunt (tips) is a minimally invasive procedure used to relieve the signs and symptoms of portal hypertension in patients with liver disease.
PubMedID- 25374709 Hepatic myelopathy or porto-systemic myelopathy is a rare neurological complication of chronic liver disease with portal hypertension, usually associated with porto-systemic shunting, and presents as pure motor spastic paraparesis without sensory or sphincter involvement.
PubMedID- 22567478 Significant morbidity is seen in those patients who develop complications such as end-stage renal diseases, chronic liver diseases with portal hypertension, and cancers associated with schistosomiasis .
PubMedID- 25420739 Variceal formation results from portal hypertension due to chronic liver disease.
PubMedID- 24771990 Chronic liver disease, especially with associated portal hypertension, has also been linked to the presence of gi angioectasias and, as reported by some authors, they could be reversed after transjugular intrahepatic portosystemic shunt .
PubMedID- 24392231 It occurs much more frequently in patients without underlying liver disease, but often leads to portal hypertension because the collateral veins are not able to adequately handle the splenic and mesenteric inflow.
PubMedID- 22973991 Objectives: transient elastography (te), as a non-invasive method, has been studied for evaluation of portal hypertension in patients with chronic liver diseases (cld) with variable results.
PubMedID- 23812037 Therefore, hscs can contribute to portal hypertension in patients with chronic liver disease (cld).
PubMedID- 24616589 Relationship between tetrahydrobiopterin and portal hypertension in patients with chronic liver disease.
PubMedID- PMC3239438 The patient was suffering from advanced liver disease with portal hypertension and multiple current inter abdominal abscesses.
PubMedID- 25147571 The most common cause of colonic varices is portal hypertension associated with liver disease or secondary to pancreatic conditions, like chronic pancreatitis or malignancies.
PubMedID- 25844525 Analysis of peritoneal fluid was consistent with portal hypertension due to liver disease.
PubMedID- 23671546 Exclusionary criteria were contraindications to wbv , severe cf (forced expiratory volume in 1 minute (fev1 < 40% predicted)), inability to stand unaided for 30 minutes, long bone or vertebral fracture in the past six months, past/present history of osteoarthritis, presence of cf-liver disease with portal hypertension, neuropathy or myopathy and/or vitamin d deficiency (25-hydroxyvitamin d < 39 nmol/l) in the past three months.
PubMedID- 25661250 This fibrotic response causes all the complications of end-stage liver disease, including portal hypertension, impaired metabolic capacity, synthetic dysfunction and ascites 1. unfortunately, currently no standard treatment for liver fibrosis is available and no appropriate antifibrotic drugs has emerged to be effective in human 6–8.
PubMedID- 20113491 This fact is, nonetheless, expected since fatty liver disease does not lead to portal hypertension and, consequently, to the widening of the portal vein.
PubMedID- 21196656 Esophageal varices develop as a consequence of portal hypertension in patients with chronic liver disease and are present in approximately 50% of patients with cirrhosis of the liver.
PubMedID- 23123767 Measuring spp using ultrasound is most simple and minimally invasive, and it might be useful for evaluating portal hypertension in dogs with liver diseases.
PubMedID- 22610002 Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease.
PubMedID- 22986694 Purpose: cystic-fibrosis-associated liver disease (cfld) may lead to portal hypertension (pht) and cirrhosis.
PubMedID- 26201624 Hepatic hydrothorax (hh) is an infrequent but a well-known complication of portal hypertension in patients with end-stage liver disease.
PubMedID- 22190914 Reported that the accuracy of their string ece for diagnosing ev and portal hypertension in patients with chronic liver disease was excellent .
PubMedID- 21932390 Targeting angiogenesis in chronic liver diseases with portal hypertension: anti-placenta growth factor inhibitor or multikinase inhibitor sorafenib.
PubMedID- 25568485 However, ultrasound examination of the abdomen revealed parenchymal liver disease with portal hypertension and ascites.
PubMedID- 21229317 Unfortunately, the patient had progressive biliary cirrhosis to end-stage liver disease complicated with portal hypertension for which she underwent successful orthotopic liver transplant at 7 years of age.
PubMedID- 22623827 He was a known case of alcoholic liver disease with portal hypertension categorised as child's class a. there was no visible caput medusae or audible periumbilical venous hum.
PubMedID- 24171010 The authors concluded that patients who carry the z allele are at greater risk (or, ≈ 5) of developing severe liver disease with portal hypertension (31).
PubMedID- 21424236 portal hypertension in the setting of decompensated liver disease is managed medically (via endoscopy) or radiologically (via transjugular intrahepatic portosystemic shunt) with the aim to offer liver transplant as a permanent solution.
PubMedID- 22059111 In most cases, no evidence of liver dysfunction is observed, and portal hypertension due to sarcoid liver diseases is a rareoccurrence.
PubMedID- 25667596 Cirrhosis is scarring of the liver and also is the final stage of many chronic liver diseases, leading to portal hypertension and end-stage liver disease 1.
PubMedID- 21685145 Background: a group of non-cirrhotic chronic liver diseases, all with sustained portal hypertension and clinically mistaken as cirrhosis, have been described under various names, apparently because of differences in pathological features.
PubMedID- 23343370 Among them there was only one patient who developed severe liver disease with portal hypertension.
PubMedID- 20065573 Background/aim: esophageal varices (evs) are a serious consequence of portal hypertension in patients with liver diseases.
PubMedID- 25646812 On the other hand, hiv coinfection accelerates hcv-related fibrosis progression with portal hypertension and hepatocellular carcinoma (hcc) .
PubMedID- 25590846 Furthermore, to exclude the effect of cardiovascular factors, patients with confirmed cardiovascular diseases or taking any agents affecting qtc interval before the establishment of achblf were excluded, such as β-blockers, even if it is recommended in patients with portal hypertension associated with chronic liver diseases.
PubMedID- 21813019 To our knowledge, ha is the only serum marker that has been confirmed as an independent predictor of portal hypertension in patients with liver disease .
PubMedID- 22689731 Here, the authors discuss a case of pancreatic ascites developing in the setting of alcoholic liver disease with portal hypertension.
PubMedID- 24803978 portal hypertension due to chronic liver disease usually requires a longer period of time.
PubMedID- 24457056 Aitp has been classified either as a primary autoimmune disorder or as secondary to a number of underlying conditions such as lymphoproliferative disorders, myelodysplasia, autoimmune collagen vascular diseases (e.g., systemic lupus erythematosus, antiphospholipid antibody syndrome) liver disease with portal hypertension, drugs or viral infection.
PubMedID- 26117383 Severe mdr3 deficiency typically presents during the first year of life or early childhood, often progressing to chronic liver disease with cirrhosis and portal hypertension, requiring liver transplantation.
PubMedID- 24714325 As the patient has chronic liver disease along with portal hypertension, he has been referred for work up for liver transplantation.
PubMedID- 24796378 Aim: liver fibrosis occurs as a result of several chronic liver diseases and leads to portal hypertension, cirrhosis and liver failure, often requiring liver transplantation.
PubMedID- 22586877 She also had diagnoses of chronic liver disease with cirrhotic changes, portal hypertension, and grade iv manageesophageal varices with hepatosplenomegaly.
PubMedID- 21978390 Markers of impaired intestinal permeability are elevated in portal hypertension, particularly with severe liver disease, and in viral and alcoholic cirrhosis .
PubMedID- 24613858 Purpose of review: cirrhosis is the result of the progression of necroinflammatory liver diseases leading to fibrosis, portal hypertension, and a catabolic state, which might cause muscle wasting or sarcopenia.
PubMedID- 24393789 Mortality is closely related to liver dysfunction or portal hypertension complications due to underlying liver disease, portal thrombosis and/or massive tumour involvement3.
PubMedID- 22662598 Clinical application of transient elastography in prediction of portal hypertension related complication in patients with chronic liver diseases.

Page: 1 2